Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1995-8-15
pubmed:abstractText
Almost 25% of patients with T-cell acute lymphoblastic leukemia (T-ALL) have tumor-specific rearrangements of the TAL1 gene. Although TAL1 expression has not been observed in normal lymphocytes, TAL1 gene products are readily detected in leukemic cells that harbor a rearranged TAL1 allele. Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL. In this report, we show that TAL1 is expressed in the leukemic cells of most patients with T-ALL, including many that do not display an apparent TAL1 gene alteration. A polymorphic dinucleotide repeat in the transcribed sequences of TAL1 was used to determine the allele specificity of TAL1 transcription in primary T-ALL cells. Monoallelic expression of TAL1 was observed in the leukemic cells of all patients (8 of 8) bearing a TAL1 gene rearrangement. In the leukemic cells of patients without detectable TAL1 rearrangements, TAL1 transcription occurred in either a monoallelic (3 of 7 patients) or a biallelic (4 of 7 patients) fashion. Thus, TAL1 activation in these patients may result from subtle alterations in cis-acting regulatory sequences (affecting expression of a single TAL1 allele) or changes in trans-acting factors that control TAL1 transcription (affecting expression of both TAL1 alleles).
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
86
pubmed:geneSymbol
TAL1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
666-76
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:7605997-Alleles, pubmed-meshheading:7605997-Base Sequence, pubmed-meshheading:7605997-Basic Helix-Loop-Helix Transcription Factors, pubmed-meshheading:7605997-Bone Marrow, pubmed-meshheading:7605997-Burkitt Lymphoma, pubmed-meshheading:7605997-Child, pubmed-meshheading:7605997-DNA, Neoplasm, pubmed-meshheading:7605997-DNA-Binding Proteins, pubmed-meshheading:7605997-Gene Expression Regulation, Leukemic, pubmed-meshheading:7605997-Gene Rearrangement, pubmed-meshheading:7605997-Humans, pubmed-meshheading:7605997-Leukemia-Lymphoma, Adult T-Cell, pubmed-meshheading:7605997-Molecular Sequence Data, pubmed-meshheading:7605997-Neoplasm Proteins, pubmed-meshheading:7605997-Neoplastic Stem Cells, pubmed-meshheading:7605997-Pleural Effusion, pubmed-meshheading:7605997-Polymerase Chain Reaction, pubmed-meshheading:7605997-Proto-Oncogene Proteins, pubmed-meshheading:7605997-T-Lymphocytes, pubmed-meshheading:7605997-Transcription Factors
pubmed:year
1995
pubmed:articleTitle
Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study.
pubmed:affiliation
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235-9048, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Multicenter Study